cert_

Written and Oral Examinations for Diplomate in Endocrinology, Diabetes and Metabolism

cert

Requirements

The following documents are required for application to take the (PSBEDM) Certifying Examination for Diplomate in Endocrinology, Diabetes and Metabolism.

  1. Certificate as Philippine College of Physicians (PCP) Diplomate.
  2. Should be a PSEM member in good standing* (certification to be obtained from PSEM secretary)
  3. Certificate of Fellowship in Endocrinology and Metabolism in a PSEM accredited Endocrinology and Metabolism training program (minimum of 2 years) or its international equivalent.
  4. One published ANALYTICAL research paper serving as a senior author in a recognized journal/publication or a certificate of acceptance for publication of the completed research paper (International, National, PJIM, and other recognized journals of the PCP components societies, or recognized institutional journals of the accredited training institutions). Case reports will not be acceptable.
  5. Endorsement of two PSEM fellows of good standing.
  6. Authenticated list of all Endocrine and Metabolic cases managed or co-managed during post-residency fellowship training. List must cover the whole range of the subspecialty (hospital case number, complete name of patients, address and telephone, complete diagnosis and disposition) as per required number of cases. The Section Chief or Training Officer must authenticate the said list.
  7. Curriculum Vitae
  8. Completed application form
  9. Payment of application and examination fee

 

Download application form

diabetes

Diabetes: Edukasyon at Aksyon, Ngayon

[ video ]

psem_logo_small

Position Statement of the Philippine Society of Endocrinology and Metabolism (PSEM) regarding the Use of Stem Cell Therapy for Diabetes Mellitus

So the public may know

 

In the last few months, proponents of stem cell therapy have issued statements to the media regarding the supposed efficacy of this approach for diabetes mellitus with claims that it can normalize blood sugars within 2 months or at least decrease the number of anti-diabetic medications.

The Philippine Society of Endocrinology and Metabolism (PSEM) would like to warn the public that there is NO cure for diabetes mellitus and that at the moment stem cell therapy is an experimental treatment for both Type 1 and Type 2 diabetes. There is as yet, no conclusive evidence that stem cell therapy is effective and safe for diabetes.

As such, stem cell therapy cannot be made available to individuals with diabetes, as a standard treatment like the usual drug prescriptions but rather, any patient who is receiving stem cell therapy for diabetes should receive it only under controlled conditions such as under experimental protocols of clinical trials. Patients receiving stem cell therapy under clinical trials should NOT pay for these experimental treatments and must sign an informed consent that explains the procedure, its benefits and possible harms. All clinical trials also need to be registered with and approved by the Food and Drug Administration (FDA) before implementation.

While it is true that stem cell therapy is labeled as promising in many reviews of its use in both Type 1 and Type 2 diabetes, it is still a science that is in in its infancy and much is not yet known about its use. Like many emerging therapies, “side effects and long-term safety must be determined, since transplanted cells may remain for many years in patients’ bodies. Therefore, careful monitoring and extended follow-up of patients who receive stem cell treatments is extremely important.” [www.isscr.org- International Society for Stem Cell Research (ISSCR) Patient Handbook].

We therefore, urge the public to refrain from availing of stem cells for the therapy of diabetes. Its use in diabetes mellitus can only be justified by research in the setting of clinical trials. Any patient who is being offered this form of therapy for diabetes should first ensure that a specialist in the treatment of diabetes is seeing them and that they are in fact being enrolled in a clinical trial. They should also verify with the FDA if such a trial is registered and approved by this agency.

Please report to the FDA any of the following:

1. Use of stem cell therapy by persons or institutions not accredited by FDA;
2. Use of stem cell therapy for diabetes mellitus outside of a clinical trial or as actual treatment;
3. Acceptance of payment for stem cell therapy when used for diabetes mellitus

Please report the above to (02) 9102253 or the FDA website: report@fda.gov.ph

research

Call for Research Papers 2014

P300,000 PSEM Research Grant in Endocrinology 2014
P200,000 PSEM-Servier Research Grant in Diabetes 2014
P150,000 PSEM-MERCK Research Grant in Diabetes 2014

 

The grants will be awarded to researches conducted by:

  1. Endocrine fellows-in-training of UP-Philippine General Hospital, Makati Medical Center, University of Santo Tomas Hospital, St. Luke’s Medical Center and The Medical City in their respective institutions.
  2. Diplomates/Fellows of PSEM conducted in a Philippine College of Physician (PCP) accredited training hospital (the diplomate/fellow may be a co-investigator).
  3. Diplomates/Fellows of PSEM in a non PSEM/PCP-accredited national or regional institution provided the diplomate/fellow is the principal author.
  4. Graduates of PSEM Research Workshops conducted with PSEM members (Founding Members, Fellows, Diplomates, Associate Members) in a PCP accredited national or regional training institutions (the PSEM members may be a co-investigator) or in a non-PCP accredited national or regional institutions provided the PSEM member is the principal author.

 

Deadline for submission of research protocols is on October 15, 2013

For further details please contact the PSEM secretariat.

Related file: Recommended format